Efficacy and tolerability of aripiprazole in adolescents with schizophrenia

被引：0
|
作者：
Forbes, A. [1 ]
Nyilas, M. [1 ]
Loze, J. [2 ]
Werner, C. [3 ]
Johnson, B. [1 ]
Owen, R. [4 ]
Todorov, S. [5 ]
Carson, W. H. [1 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
[2] Otsuka Pharmaceut France SAS, Rueil Malmaison, France
[3] Otsuka Frankfurt Res Inst, Frankfurt, Germany
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[5] Multiprofiled Hosp Act Treatment, Psychiat Clin 1, Varna, Bulgaria
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.786
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [31] Meta-analysis of the efficacy of aripiprazole in schizophrenia
    Carson, WH
    Stock, E
    Saha, AR
    Ali, MW
    McQuade, RD
    Kujawa, MJ
    Ingenito, G
    EUROPEAN PSYCHIATRY, 2002, 17 : 105S - 105S
  • [32] Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis
    Krause, M.
    Zhu, Y.
    Schneider-Thoma, J.
    Huhn, M.
    Salanti, G.
    Chaimani, A.
    Leucht, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S948 - S948
  • [33] Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
    Krause, Marc
    Zhu, Yikang
    Huhn, Maximilian
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Chaimani, Anna
    Leucht, Stefan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (06) : 659 - 674
  • [34] Neurocognitive effects of aripiprazole in adolescents and young adults with schizophrenia
    Yeh, Chin-Bin
    Huang, Yu-Shu
    Tang, Ching-Shu
    Wang, Liang-Jen
    Chou, Wen-Jiun
    Chou, Miao-Chun
    Chen, Chih-Ken
    NORDIC JOURNAL OF PSYCHIATRY, 2014, 68 (03) : 219 - 224
  • [35] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [36] ARIPIPRAZOLE IN ADOLESCENTS WITH INTELLECTUAL DISABILITIES AND SCHIZOPHRENIA: A CASE REPORT
    Giannakopoulos, G.
    Charitaki, S.
    Kotzia, T.
    Kolaitis, G.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [37] Efficacy and tolerability of aripiprazole depot in schizoaffective disorder: Case report
    Garcia Moreno, M.
    de Cos Milas, A.
    Beatobe Carreno, L.
    Poza Cano, B.
    EUROPEAN PSYCHIATRY, 2018, 48 : S527 - S527
  • [38] Varenicline efficacy and tolerability in a subject with schizophrenia
    Fatemi, S. Hossein
    SCHIZOPHRENIA RESEARCH, 2008, 103 (1-3) : 328 - 329
  • [39] Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability
    DeLeon, A
    Patel, NC
    Crismon, ML
    CLINICAL THERAPEUTICS, 2004, 26 (05) : 649 - 666
  • [40] Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
    Andrea Fagiolini
    Annals of General Psychiatry, 9 (Suppl 1)
12345